Trexquant Investment LP Ocular Therapeutix, Inc Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.01 - $5.22 $214,384 - $371,789	-71,224 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $344,011 - $523,496	71,224 New	71,224 $353,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $226,934 - $444,658	-36,840 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $199,373 - $294,744	20,554 Added 126.21%	36,840 $368,000
Q2 2021 Aug 12, 2021	SELL	$13.43 - $19.16 $201,141 - $286,959	-14,977 Reduced 47.91%	16,286 $231,000
Q1 2021 May 13, 2021	BUY	$15.82 - $22.11 $494,580 - $691,224	31,263 New	31,263 $513,000
Q4 2020 Feb 11, 2021	SELL	$7.91 - $22.95 $259,376 - $752,553	-32,791 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$7.36 - $9.87 $151,167 - $202,719	20,539 Added 167.64%	32,791 $250,000
Q2 2020 Aug 07, 2020	BUY	$4.67 - $8.95 $57,216 - $109,655	12,252 New	12,252 $102,000
Q4 2018 Feb 13, 2019	SELL	$3.87 - $7.11 $78,135 - $143,550	-20,190 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$5.42 - $6.99 $109,429 - $141,128	20,190 New	20,190 $139,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.